Title: National and International Spread of Antimicrobial Resistance: Clones and Genes
1National and International Spread of
Antimicrobial Resistance Clones and Genes
Professor Alan Johnson, Health Protection
Services - HPA
2Antimicrobial Resistance
- Streptococcus pneumoniae
- Staphylococcus aureus
- Escherichia coli
3Global Spread of Multi-Resistant Clone of
Streptococcus pneumoniae (Spain23F-1)
Finland
France BM4200 1978 ?
Cleveland
Spain
South Korea
Tennessee
Taiwan
Mexico
Hong Kong
Philippines
Thailand
Colombia
Malaysia
Singapore
Brazil
Chile
South Africa
Uruguay
Argentina
Munoz et al . J Infect Dis 1991 164302-06
4Pneumococcal Molecular Epidemiology Network
Clone Serotype Resistance pattern
Spain23F-1 23F PEN, CHL, TET
Spain6B-2 6B PEN, CHL, TET
Spain9V-3 9V PEN
Tennessee23F-4 23F CTX, ERY
Spain14-5 14 PEN, CHL, TET
Hungary19A-6 19A PEN, ERY, CLIN, CHL, TET
S. Africa19A-7 19A PEN
S. Africa6B-8 6B PEN
England14-9 14 ERY
SCR14-10 14 PEN, ERY, CLIN, CHL, TET
PMEN, Pneumococcal Molecular Epidemiology
Network http//www.sph.emory.edu/PMEN/
5Pneumococcal Bacteraemia in a British District
General Hospital, Jan 2000-Mar 2001
- 56 cases of pneumococcal bacteraemia
- 18 isolates (32) were antibiotic-resistant
- Three isolates of Spain9V-3 clone (pen-R)
- 14 isolates of England14-9 clone (ery-R)
- One isolate of Spain6B-2 clone (multi-R)
Birtles A et al. J Med Microbiol 2004 53
1241-1246
6Pneumococcal vaccines
- Pneumococci comprise 90 serotypes
- Polysaccharide capsule is a virulence
determinant (inhibits phagocytosis) - Capsule antigens form basis for vaccines
- 7-valent conjugate vaccine (2006)
- 13-valent conjugate vaccine
7Erythromycin Resistance in Invasive Pneumococci,
England and Wales
PCV-7
2mo to lt2yrs
Older patients
Henderson K et al. J Antimicrob Chemother 2010
65 369-70.
8Bacteraemia Due to MRSA, England Wales
MRSA
9Hospitals in England Wales Sending EMRSA-15/16
to Reference Laboratory
10Correlation of MRSA and Use of Macrolides,
Cephalosporins and Fluoroquinolones
Monnet DL et al. EID 2004 101432-41.
11Spread of EMRSA-15/16
- Ciprofloxacin is excreted in sweat
- Disruption of normal skin microflora?
- Colonization of skin by ciprofloxacin-resistant
MRSA?
12Distribution of MRSA Spa Types in Europe
13Epidemiology of Cephalosporin Resistance in UK is
Changing
- 1980-90s
- Nosocomial (e.g. ICUs)
- Commonly Klebsiella spp.
- TEM/SHV ESBLs
- Since 2003
- Commonly E. coli
- CTX-M type ESBLs
- UTIs in elderly patients in the community
(difficult to determine if community or HCAI)
14PFGE Profile of CTX-M-producing E. coli
- 5 related strains
- Serotype O25H4
- MLST 131
Woodford N et al.J Antimicrob Chemother 2004 54
735-43
15Spread of E. coli Strain A
- CTX-M-15
- Serotype O25H4
- Sequence type 131
- Global spread
16International Spread of E. coli 025H4 ST131 with
CTX-M-15
17PFGE Profile of CTX-M-producing E. coli
- 5 related strains
- Serotype O25H4
- MLST 131
Woodford N et al.J Antimicrob Chemother 2004 54
735-43
18Bacterial Plasmids
19Conjugating bacteria
20Spread of AMR
- Vancomycin-resistant enterococci
- Klebsiella pneumoniae
- Acinetobacter baumanii
- MDR TB
- Cephalosporin-resistant gonococci
- Carbapenemase-producing Gram-negative bacteria
21What We Do and Dont Know
- Antibiotic resistance involves both strain and
gene spread - Why are some strains epidemic and others not?
- How do we prevent strain spread
(local/national/international)? - Can we prevent plasmid spread?
- How important is plasmid spread in the gut?
- Epidemiology of resistance in commensal
bacteria? - Interventions (e.g. rapid tests antibiotic
stewardship)?
22(No Transcript)